Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.45 |
| ▸ | TUBB | P07437 | 1/20 | 0.45 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.45 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.45 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.45 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.45 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.45 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.45 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.45 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.45 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.45 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.45 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.45 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.45 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29421891 | 1.00 | EPHX2 (0.57) | EPHX2CYP3A4MAPTACHETUBB4A | |
| SCHEMBL1808984 | 0.86 | EPHX2 (0.49) | EPHX2CYP3A4MAPTACHETDP1 | |
| SCHEMBL4127825 | 0.86 | MAPT (0.54) | EPHX2CYP3A4MAPTACHETUBB4A | |
| SCHEMBL5587869 | 0.84 | MAPT (0.56) | CYP3A4MAPTACHETUBB4ATUBB | |
| Benzene SCHEMBL28616661 | 0.83 | EPHX2 (0.46) | EPHX2CYP3A4MAPTACHETDP1 | |
| SCHEMBL11333975 | 0.82 | EPHX2 (0.43) | EPHX2CYP3A4MAPTACHETUBB4A | |
| SCHEMBL3678118 | 0.82 | MAPT (0.48) | EPHX2CYP3A4MAPTACHETDP1 | |
| SCHEMBL27553867 | 0.81 | MAPT (0.58) | EPHX2CYP3A4MAPTACHETDP1 | |
| SCHEMBL20123234 | 0.81 | TDP1 (0.48) | EPHX2CYP3A4MAPTACHETDP1 | |
| SCHEMBL12587650 | 0.80 | MAPT (0.52) | EPHX2CYP3A4MAPTACHETUBB4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114181047-A | Method for preparing biphenol from cresol | 中国科学院大连化学物理研究所 | 2022-03-15 | — | — | CN | claimed |
| CN-109276563-B | Application of pharmaceutical composition in preparing medicine for treating or preventing individual infection virus | 珠海市鑫展生物科技有限公司 | 2021-04-09 | — | — | CN | claimed |
| CN-105567923-A | Rubber lining processing method of metal valve plate of soft sealing valve | ANHUI TONGLING KELI VALVE CO LTD | 2016-05-11 | — | — | CN | claimed |
| CN-105567915-A | Heat treatment method of valve plate sealing face | ANHUI TONGLING KELI VALVE CO LTD | 2016-05-11 | — | — | CN | claimed |
| EP-1915333-B1 | PROCESS FOR THE PREPARATION OF UBIHYDROQUINONES AND UBIQUINONES | DSM IP ASSETS BV (NL) | 2015-06-03 | — | — | EP | claimed |
| CN-102775290-A | Preparation method of 2-(chloromethyl)-5,6-dimethoxy-3-methyl-1,4-para benzoquinone | UNIV KUNMING SCIENCE & TECHNOLOGY | 2012-11-14 | — | — | CN | claimed |
| CN-101243031-B | Process for preparing ubiquinones and ubiquinones | DSM IP ASSETS BV | 2012-05-09 | — | — | CN | claimed |
| CN-1800131-B | 2,3,4,5-tetramethoxyl toluene synthesis method | JIANGSU YABANG PHARMACEUTICAL RES & DEV CO LTD | 2011-01-05 | — | — | CN | claimed |
| US-7601877-B2 | Condensation of a prenol or isoprenol with a hydroquinone or derivative in the presence of 0.005-1.0 mol percent of a Bronsted or Lewis acid catalyst selected from a bismuth, indium or Group 3 chloride, a heteropolyacid, and an NH- or a CH-acidic compound, oxidizing the ubihydroquinone; improved kinetics | DSM IP ASSETS B.V. (NL) | 2009-10-13 | — | — | US | claimed |
| US-20080275275-A1 | Process for the Preparation of Ubihydroquinones and Ubiquinones | DSM IPASSETS B.V. (NL) | 2008-11-06 | — | — | US | claimed |
| CN-101243031-A | Process for the preparation of ubihydroquinones and ubiquinones | DSM IP ASSETS BV (NL) | 2008-08-13 | — | — | CN | claimed |
| EP-1915333-A1 | PROCESS FOR THE PREPARATION OF UBIHYDROQUINONES AND UBIQUINONES | DSMIP Assets B.V. (NL) | 2008-04-30 | — | — | EP | claimed |
| WO-2007017168-A1 | PROCESS FOR THE PREPARATION OF UBIHYDROQUINONES AND UBIQUINONES | DSM IP ASSETS B.V. (NL) | 2007-02-15 | — | — | WO | claimed |
| CN-1800131-A | 2,3,4,5-tetramethoxyl toluene synthesis method | JIANGSU YABANG PHARMACEUTICAL (CN) | 2006-07-12 | — | — | CN | claimed |
| US-4163864-A | Process for preparing 2-methyl-3-prenyl-4,5,6-trimethoxyphenol | EISAI CO., LTD. (JP) | 1979-08-07 | — | — | US | claimed |
| US-4062879-A | Process for synthesis of coenzyme Q compounds | EISAI CO., LTD. (JA) | 1977-12-13 | — | — | US | claimed |
| US-4061660-A | Process for synthesis of coenzyme Q compounds | EISAI CO., LTD. (JA) | 1977-12-06 | — | — | US | claimed |
| JP-52042837-A | — | — | None | — | — | JP | disclosed |
| JP-S5242837-A | SYNTHETIC PROCESS FOR COENZYME Q GROUP COMPOUNDS | EISAI CO LTD | 1977-04-04 | — | — | JP | disclosed |
| JP-S5242835-A | PROCESS FOR PREPARATION OF 6-METHYL-2,3,4-TRIMETHOXYPHENOL | EISAI CO LTD | 1977-04-04 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275275-A1 | Process for the Preparation of Ubihydroquinones and Ubiquinones | UBE2D3, UBE2L3, UBE2I | EPHX2 328/4885CYP3A4 694/4885MAPT 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.